{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:30:46Z","timestamp":1792539046099,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"DOI":"10.7759\/cureus.103015","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:01:47Z","timestamp":1770292907000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Lidocaine Infusion in the Management of Chronic Myofascial Pain and Intractable Migrainous Headache in a Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Roy","family":"Sebastian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchana","family":"Gattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8628(19980428)77:1<31::aid-ajmg8>3.0.co;2-o","article-title":"Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)","volume":"77","author":"Beighton P","year":"1998","unstructured":"Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998, 77:31-7. 10.1002\/(sici)1096-8628(19980428)77:1&lt;31::aid-ajmg8&gt;3.0.co;2-o","journal-title":"Am J Med Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers-Danlos syndromes","volume":"175","author":"Malfait F","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, et al.. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017, 175:8-26. 10.1002\/ajmg.c.31552","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14165636","article-title":"Defining the chronic complexities of hEDS and HSD: a global survey of diagnostic challenges, life-long comorbidities, and unmet needs","volume":"14","author":"Daylor V","year":"2025","unstructured":"Daylor V, Griggs M, Weintraub A, et al.. Defining the chronic complexities of hEDS and HSD: a global survey of diagnostic challenges, life-long comorbidities, and unmet needs. J Clin Med. 2025, 14:10.3390\/jcm14165636","journal-title":"J Clin Med"},{"key":"ref4","article-title":"Hypermobile Ehlers-Danlos syndrome","author":"Hakim A","year":"2004","unstructured":"Hakim A. Hypermobile Ehlers-Danlos syndrome.  Adam MP, Bick S, Mirzaa GM, et al. (ed): GeneReviews\u00ae. University of Washington, Seattle; 2004."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31950","article-title":"Pain in the Ehlers-Danlos syndromes: mechanisms, models, and challenges","volume":"187","author":"Malfait F","year":"2021","unstructured":"Malfait F, Colman M, Vroman R, et al.. Pain in the Ehlers-Danlos syndromes: mechanisms, models, and challenges. Am J Med Genet C Semin Med Genet. 2021, 187:429-45. 10.1002\/ajmg.c.31950","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.4754","article-title":"Exploring signs of central sensitization in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome","volume":"29","author":"Schubert-Hjalmarsson E","year":"2025","unstructured":"Schubert-Hjalmarsson E, Fasth A, Ickmans K, S\u00f6derpalm AC, Lundberg M. Exploring signs of central sensitization in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome. Eur J Pain. 2025, 29:e4754. 10.1002\/ejp.4754","journal-title":"Eur J Pain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31940","article-title":"Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome\/hypermobility spectrum disorder","volume":"187","author":"Brock I","year":"2021","unstructured":"Brock I, Prendergast W, Maitland A. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome\/hypermobility spectrum disorder. Am J Med Genet C Semin Med Genet. 2021, 187:473-81. 10.1002\/ajmg.c.31940","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2016.07.021","article-title":"Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial","volume":"35","author":"Ortiz MP","year":"2016","unstructured":"Ortiz MP, Godoy MC, Schlosser RS, et al.. Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial. J Clin Anesth. 2016, 35:70-7. 10.1016\/j.jclinane.2016.07.021","journal-title":"J Clin Anesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04832-4","article-title":"The Beighton Score as a measure of generalised joint hypermobility","volume":"41","author":"Malek S","year":"2021","unstructured":"Malek S, Reinhold EJ, Pearce GS. The Beighton Score as a measure of generalised joint hypermobility. Rheumatol Int. 2021, 41:1707-16. 10.1007\/s00296-021-04832-4","journal-title":"Rheumatol Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16847","article-title":"Assessment of functional pain score by comparing to traditional pain scores","volume":"13","author":"Adeboye A","year":"2021","unstructured":"Adeboye A, Hart R, Senapathi SH, Ali N, Holman L, Thomas HW. Assessment of functional pain score by comparing to traditional pain scores. Cureus. 2021, 13:e16847. 10.7759\/cureus.16847","journal-title":"Cureus"},{"key":"ref11","article-title":"Trigger points: diagnosis and management","volume":"65","author":"Alvarez DJ","year":"2002","unstructured":"Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002, 65:653-60.","journal-title":"Am Fam Physician"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.19.25336146","article-title":"Complex genetics and regulatory drivers of hypermobile ehlers-danlos syndrome: insights from genome-wide association study meta-analysis","author":"Petrucci-Nelson T","year":"2025","unstructured":"Petrucci-Nelson T, Guilhaumou S, Berrandou TE, et al.. Complex genetics and regulatory drivers of hypermobile ehlers-danlos syndrome: insights from genome-wide association study meta-analysis. medRxiv. 2025, 10.1101\/2025.09.19.25336146","journal-title":"medRxiv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.70000","article-title":"The impact of pain on everyday activities of people with hypermobility spectrum disorders or hypermobility Ehlers Danlos Syndrome","volume":"29","author":"Lindholm S","year":"2025","unstructured":"Lindholm S, Petersson S, Molander P, Bj\u00f6rk M. The impact of pain on everyday activities of people with hypermobility spectrum disorders or hypermobility Ehlers Danlos Syndrome. Eur J Pain. 2025, 29:e70000. 10.1002\/ejp.70000","journal-title":"Eur J Pain"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1460352","article-title":"Headache disorders in patients with Ehlers-Danlos syndromes and hypermobility spectrum disorders","volume":"15","author":"Mehta D","year":"2024","unstructured":"Mehta D, Simmonds L, Hakim AJ, Matharu M. Headache disorders in patients with Ehlers-Danlos syndromes and hypermobility spectrum disorders. Front Neurol. 2024, 15:1460352. 10.3389\/fneur.2024.1460352","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125587","article-title":"Fascial pathophysiology in hypermobility spectrum disorders and hypermobile ehlers-danlos syndrome: a review of emerging evidence","volume":"26","author":"Wang TJ","year":"2025","unstructured":"Wang TJ, Stecco A, Hakim AJ, Schleip R. Fascial pathophysiology in hypermobility spectrum disorders and hypermobile ehlers-danlos syndrome: a review of emerging evidence. Int J Mol Sci. 2025, 26:10.3390\/ijms26125587","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1648702","article-title":"Neurobiological and neuropsychological disturbance in EDS","volume":"16","author":"Westerman M","year":"2025","unstructured":"Westerman M, Kafkas A, Parry-Jones A, Strong S, Retzler C, Hallam G. Neurobiological and neuropsychological disturbance in EDS. Front Neurol. 2025, 16:1648702. 10.3389\/fneur.2025.1648702","journal-title":"Front Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4495","article-title":"Intravenous lidocaine for the management of chronic pain: a narrative review of randomized clinical trials","volume":"54","author":"Onyeaka H","year":"2024","unstructured":"Onyeaka H, Adeola J, Xu R, et al.. Intravenous lidocaine for the management of chronic pain: a narrative review of randomized clinical trials. Psychopharmacol Bull. 2024, 54:73-96. 10.64719\/pb.4495","journal-title":"Psychopharmacol Bull"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113883","article-title":"Anti-inflammatory and immunomodulatory effects of intravenous lidocaine in surgery: a narrative review","volume":"14","author":"Fern\u00e1ndez-Mart\u00ednez A","year":"2025","unstructured":"Fern\u00e1ndez-Mart\u00ednez A, Garc\u00eda JG, L\u00f3pez-Picado A. Anti-inflammatory and immunomodulatory effects of intravenous lidocaine in surgery: a narrative review. J Clin Med. 2025, 14:10.3390\/jcm14113883","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103180","article-title":"Lidocaine infusions for refractory chronic migraine: a retrospective analysis","volume":"47","author":"Schwenk ES","year":"2022","unstructured":"Schwenk ES, Walter A, Torjman MC, et al.. Lidocaine infusions for refractory chronic migraine: a retrospective analysis. Reg Anesth Pain Med. 2022, 47:408-13. 10.1136\/rapm-2021-103180","journal-title":"Reg Anesth Pain Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15270","article-title":"The use of intravenous lidocaine for postoperative pain and recovery: international consensus statement on efficacy and safety","volume":"76","author":"Foo I","year":"2021","unstructured":"Foo I, Macfarlane AJ, Srivastava D, et al.. The use of intravenous lidocaine for postoperative pain and recovery: international consensus statement on efficacy and safety. Anaesthesia. 2021, 76:238-50. 10.1111\/anae.15270","journal-title":"Anaesthesia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00954","article-title":"Intra-venous lidocaine to relieve neuropathic pain: a systematic review and meta-analysis","volume":"10","author":"Zhu B","year":"2019","unstructured":"Zhu B, Zhou X, Zhou Q, Wang H, Wang S, Luo K. Intra-venous lidocaine to relieve neuropathic pain: a systematic review and meta-analysis. Front Neurol. 2019, 10:954. 10.3389\/fneur.2019.00954","journal-title":"Front Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S379208","article-title":"Intravenous lidocaine for treatment of chronic pain: a retrospective cohort study","volume":"15","author":"Horvat S","year":"2022","unstructured":"Horvat S, Staffhorst B, Cobben JM. Intravenous lidocaine for treatment of chronic pain: a retrospective cohort study. J Pain Res. 2022, 15:3459-67. 10.2147\/JPR.S379208","journal-title":"J Pain Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23310","article-title":"Lidocaine infusion: an antiarrhythmic with neurologic toxicities","volume":"14","author":"Daraz YM","year":"2022","unstructured":"Daraz YM, Abdelghffar OH. Lidocaine infusion: an antiarrhythmic with neurologic toxicities. Cureus. 2022, 14:e23310. 10.7759\/cureus.23310","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/449442-efficacy-of-lidocaine-infusion-in-the-management-of-chronic-myofascial-pain-and-intractable-migrainous-headache-in-a-patient-with-hypermobile-ehlers-danlos-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:01:48Z","timestamp":1770292908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/449442-efficacy-of-lidocaine-infusion-in-the-management-of-chronic-myofascial-pain-and-intractable-migrainous-headache-in-a-patient-with-hypermobile-ehlers-danlos-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.103015","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}